Navigation Links
Will Loss of Lethal Injection Drug Harm Surgical Patients?
Date:1/29/2011

By Dennis Thompson
HealthDay Reporter

FRIDAY, Jan. 28 (HealthDay News) -- Anesthesiologists say they have grave concerns over a decision by a drug manufacturer to halt production of a long-used and powerful anesthetic because of the medication's use in lethal injections in prison executions.

Hospira, of Lake Forest, Ill., had intended to produce Pentothal (sodium thiopental) at its plant in Italy, but abandoned that plan last week when authorities there demanded that the drug not be used for executions in America.

There are no other sources of Pentothal available to American physicians, and experts noted that while there are newer anesthetics on the market, Pentothal is a safer alternative for certain patients because it does not lower blood pressure as drastically as its newer counterparts do.

The American Society of Anesthesiologists (ASA) issued a statement saying that its members are "extremely troubled" that they will no longer have access to Pentothal, which has been used in preoperative sedation since the 1940s.

"We've seen the fairly sudden disappearance of a very common and popular drug," said ASA president-elect Dr. Jerry Cohen, an associate professor of anesthesiology at the University of Florida College of Medicine. "It's a drug we would be better off having because it serves certain numbers of our patients, and we put them at higher risk when we use alternatives. This is going to be a real problem for safety."

Pentothal used to be the most widely used drug for preoperative medication, but has been superseded by newer anesthetics such as propofol and etomidate, explained Bona E. Benjamin, director of medication-use quality improvement for the practice development division of the American Society of Health-System Pharmacists.

However, Pentothal is often preferred for certain types of patients, usually because it does not cause blood pressure to drop as severely for an extended period
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
2. Potentially Lethal Airborne Fungus May Spread to California
3. Decline in Potentially Lethal Hospital-Based Infections
4. A lethal brain tumors strength may be a weakness as well
5. Synthetic lethality strategy improves molecularly targeted cancer therapy
6. Surprise finding: Pancreatic cancers progress to lethal stage slowly
7. Antifreeze a Sweet But Lethal Drink for Pets
8. Even One Cigarette Can Prove Lethal, U.S. Surgeon General Says
9. FDA Issues Warning on Fat-Melting Spa Injections
10. Injection Helps Treat Hard-to-Control Type 2 Diabetes
11. Botox Injections May Relieve Tennis Elbow Pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Will Loss of Lethal Injection Drug Harm Surgical Patients?
(Date:2/26/2015)... (PRWEB) February 26, 2015 SpendWell ... celebrated its launch to its first customer today, ... and their covered dependents. , SpendWell delivers ... care services, combining real-time price transparency with e-commerce. ... variety of routine health care services and allows ...
(Date:2/26/2015)... 26, 2015 In a nested-case control study ... world with a relatively low incidence of liver cancer, statin ... according to a new study published February 26 ... , Previous studies have reported this association but most used ... cancer incidence rate, such as Asia. Katherine A. McGlynn, Ph.D., ...
(Date:2/26/2015)... February 26, 2015 The Reproductive Science ... their newly renovated office in Lawrenceville, NJ. ... Center of New Jersey’s physicians, and NJ Top Docs, ... care in the areas of infertility and reproductive medicine. ... excellent success rates and providing current, high quality medical ...
(Date:2/26/2015)... Austin, Texas (PRWEB) February 26, 2015 The ... only enabled local pastor and Central Texas resident John Short ... so much, he has set out to climb Mt. Kilimanjaro, ... to help stop human trafficking. , Starting in his late ... worsened and eventually his hip bones and sockets were bone ...
(Date:2/26/2015)... 2015 Eating disorders are serious, ... adulthood. In response to emerging research regarding eating ... of National Eating Disorders Awareness Week, the Society ... evidence-based recommendations for the medical management of restrictive ... a new approach to assessing the degree of ...
Breaking Medicine News(10 mins):Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 2Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 3
... May 13 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE ... scheduled a conference call to discuss the first quarter ... general business update on Monday, May 18, 2009 at ... please dial (800) 357-0498, for international callers dial (850) ...
... help educate people about the importance of working ... Store, America,s leading provider of power wheelchairs and ... May 4-8. The company joined professional compliance organizations ... ongoing efforts to reinforce their commitments to integrity ...
... First Boston Pharma announces the acquisition of ... of solid dose and soft chew pharmaceuticals and supplements. ... Pharma, LLC. Leading the First Boston Pharma organization ... one of the industry,s foremost innovators in over-the-counter ("OTC") ...
... Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced ... Annual Health Care Conference in Boston, Massachusetts, on May 19, ... presentation can be accessed via Zimmer,s Investor Relations website at ... will be archived for replay following the conference. About the ...
... Sales Will Command 54 percent of the Market by ... WALTHAM, Mass., May 13 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that the non-small-cell lung ... 2013, growing from $27.7 million in 2008 to $52.1 ...
... SHENZHEN, China, May 13 /PRNewswire-Asia/ -- Winner Medical Group Inc.,(OTC ... financial results for the second quarter ended March 31,2009. The ... with,the United States Securities and Exchange Commission. , , ... Total net sales revenue increased by 15.31% over the second ...
Cached Medicine News:Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2009 and to Provide a Business Update 2Health News:The SCOOTER Store Recognizes National Corporate Compliance & Ethics Week 2Health News:First Boston Pharma, LLC Acquires NutraMax Products, Inc. 2Health News:India's Non-Small-Cell Lung Cancer Drug Market Will Almost Double by 2013 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 4Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 5Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 6Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 7Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 8Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 9Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 10Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 11
(Date:2/26/2015)... Feb. 26, 2015  Lyric Pharmaceuticals Inc. today announced ... totaling $20.4 million. The financing, co-led by RiverVest Venture ... by Aperture Venture Partners. Lyric is ... David Wurtman , M.D., M.B.A., President & Chief Executive ... Medical Officer.  In 2014, Lyric closed a seed financing ...
(Date:2/26/2015)... Feb. 26, 2015 Columbia Laboratories, Inc. ... Company"), a specialty pharmaceutical company focused on the ... initiate a Phase II clinical trial for COL-1077, ... transvaginal pipelle-directed endometrial biopsy in the second quarter ... ("IND") submission feedback from the United States Food ...
(Date:2/26/2015)...  Great Basin Scientific, Inc. ("Great Basin") announced today ... of up to 2,724,000 units at $8.80 per Unit.  ... preferred stock and eight Series C warrants.  Each share ... four shares of common stock and each Series C ... stock at an exercise price of $2.55 per share.  ...
Breaking Medicine Technology:Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: